Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
Public ClinicalTrials.gov record NCT03048825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 2x2 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients with Myocardial Infarction / SYNERGY Stent Registry - Organization to Assess Strategies for Ischemic Syndromes 9
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The CLEAR SYNERGY trial will study the long term effects of treatments following PCI to treat myocardial infarction. These treatments address both the culprit artery (PCI with SYNERGY stent) as well as the non-culprit arteries (randomization to routine colchicine and spironolactone).
Study identification
- NCT ID
- NCT03048825
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 7,264 participants
Conditions and interventions
Interventions
- Colchicine Drug
- Spironolactone Drug
- SYNERGY Bioabsorbable Polymer Drug-Eluting Stent Device
- Colchicine-Placebo Drug
- Spironolactone-Placebo Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 1, 2018 (Actual)
- Primary completion
- Aug 9, 2024 (Actual)
- Completion
- Aug 9, 2024 (Actual)
- Last update posted
- Oct 15, 2024
2018 – 2024
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Cardiology | Bakersfield | California | 93308 | — |
| Medstar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| University of Illinois | Chicago | Illinois | 60612 | — |
| Prairie Education & Research Cooperative | Springfield | Illinois | 62769 | — |
| Community Hospital | Munster | Indiana | 46321 | — |
| Lahey Hospital and Medical Center | Burlington | Massachusetts | 01805 | — |
| New Mexico Heart Institute | Albuquerque | New Mexico | 87102 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| The Christ Hospital Lindner Research Center | Cincinnati | Ohio | 45219 | — |
| Penn State Health Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03048825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03048825 live on ClinicalTrials.gov.